Clinical Trials

Glioblastoma, Glioma

NCT05718778 2024-02-07

Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma

31 enrolled

Sarcoma

NCT02556762 2024-02-06

SUMC-EC-002

202 enrolled

Esophageal Neoplasms

NCT05385926 2024-02-05

Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

34 enrolled

Nasopharyngeal Neoplasms

NCT03503630 2024-01-31

Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

44 enrolled

Locally Advanced Rectal Cancer

NCT05647590 2024-01-30

SBRT/RT in Oligometastatic Stage IV NSCLC

10 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05092412 2024-01-12

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Phase EARLY_PHASE1 Unknown

30 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05607017 2024-01-12

Losartan in Prevention of Radiation-Induced Heart Failure

10 enrolled

Radiation Fibrosis Syndrome, Breast Neoplasms

NCT02037048 2024-01-08

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

63 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03935256 2023-12-18

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

24 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT03620032 2023-12-06

DIPG

54 enrolled

Diffuse Intrinsic Pontine Glioma

NCT03341520 2023-11-30

GAZAI

89 enrolled

Lymphoid

Lymphoma, Follicular

NCT03729687 2023-11-30

LARCT-US

280 enrolled

Rectal Neoplasms

NCT05588219 2023-11-24

Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

30 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02229656 2023-11-07

Olaparib and Radiotherapy in Head and Neck Cancer

Phase 1 Unknown

12 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT06120127 2023-11-07

IMPROVE

80 enrolled

Colorectal Neoplasms

NCT00411138 2023-10-11

PORTEC-3

670 enrolled

Gynecologic

Endometrial Neoplasms

NCT05010434 2023-09-21

Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma

46 enrolled

Carcinoma, Hepatocellular

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

30 enrolled

Tumor-Agnostic

Neoplasms

NCT05783076 2023-08-30

SBRT Plus vNKT for Pancreatic Cancer

29 enrolled

Pancreatic Neoplasms

NCT03790553 2023-08-03

Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma

646 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02679040 2023-07-03

HIST-RIC

101 enrolled

Breast Neoplasms

NCT05603065 2023-06-29

TINES

Phase 4 Unknown

32 enrolled

Esophageal Squamous Cell Carcinoma

NCT05868317 2023-05-22

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

70 enrolled

Rectal Neoplasms

NCT03691441 2023-05-17

Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer

Phase 4 Unknown

280 enrolled

Oropharyngeal Neoplasms

NCT02288195 2023-05-12

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

663 enrolled

Rectal Neoplasms

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

60 enrolled

Tumor-Agnostic

Neoplasms

NCT04030260 2023-03-23

Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

28 enrolled

Colorectal Cancer Metastatic

NCT01590355 2023-03-08

ORATOR

68 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05755009 2023-03-07

ST-CR01

33 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05749042 2023-03-01

A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

70 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT01968538 2023-02-28

Metabolomic Study for Localized Prostate Cancer

400 enrolled

Prostatic Neoplasms

NCT01618851 2023-02-22

Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer

70 enrolled

Prostatic Neoplasms

NCT04359199 2023-02-10

QUASAR

42 enrolled

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT02025036 2023-02-08

CRTCOESC

249 enrolled

Esophageal Squamous Cell Carcinoma

NCT02766686 2023-02-08

ProtoChoice-P

146 enrolled

Prostatic Neoplasms

NCT05225116 2023-02-08

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Phase 1 Unknown

20 enrolled

Carcinoma, Hepatocellular

NCT04815616 2023-02-01

Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study).

47 enrolled

Breast Neoplasms

NCT05708391 2023-02-01

Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children

53 enrolled

Sarcoma

Rhabdomyosarcoma

NCT02125396 2023-01-27

ARTC-HCC

150 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05690399 2023-01-19

Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer

Prostatic Neoplasms

NCT05680194 2023-01-11

EEBC

1,000 enrolled

Breast Neoplasms

NCT05659186 2022-12-21

PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer

20 enrolled

Thyroid Neoplasms

NCT05635149 2022-12-02

Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer

Colorectal Adenocarcinoma

NCT00887380 2022-11-18

STARS

2,023 enrolled

Breast Neoplasms

NCT05616377 2022-11-15

CLTBME

2,000 enrolled

Brain Neoplasms

NCT05602415 2022-11-02

Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

41 enrolled

Sarcoma

NCT05603013 2022-11-02

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

45 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05305885 2022-09-30

Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis